In general, the incidence of cancer in women has not declined as rapidly. Also, breast cancer in black women has a much higher mortality rate than...
The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
December 15, 2022 — Only 14.1% of cancer cases in the United States are diagnosed with recommended screening tests, says a new report. Instead, according to...
Brittany Hawkins was diagnosed with stage IV lung cancer and given 3-6 months to live. Then her biomarker test led to targeted therapy and everything changed....
A common misconception about lung cancer is that it only affects certain people, such as the elderly and those who have smoked. But when it comes...
Recent studies highlight the importance of regular CT screening for improving survival outcomes in lung cancer. Despite advances in targeted therapy and immunotherapy, results from 20...
Recent Comments